Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.5B | 4.3B | 4.5B | 4.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.5B | 1.4B | 1.5B | 1.4B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.7B | 1.6B | 1.7B | 1.5B |
| Tax provision | 383.9M | 364.2M | 406.1M | 323.5M |
| Net income | 1.3B | 1.2B | 1.3B | 1.2B |
| Basic EPS | 2.2 | 2.1 | 2.2 | — |
| Diluted EPS | 2.2 | 2.0 | 2.2 | — |
| Basic average shares | 574.5M | 578.3M | 580.5M | — |
| Diluted average shares | 577.7M | 580.9M | 583.8M | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.3B | 1.2B | 1.3B | 1.2B |
| Minority interests | -1.2M | -5.5M | -4.9M | -4.9M |
| Preferred stock dividends | — | — | — | — |